Concepedia

Author

Michal Stark

Technion – Israel Institute of TechnologyORCID

Also Known As

M Stark, M. Stark, Michal Stark, Stark, Michal

39

Publications

1.3K

Citations

18

H-Index

45

Concepts

All Affiliations

Technion – Israel Institute of TechnologyAmsterdam UMC Location Vrije Universiteit AmsterdamVrije Universiteit Amsterdam
MS

About

Michal Stark is an author at Technion – Israel Institute of Technology specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

424

2

Biochemistry

4

4

140

3

Health Sciences

3

3

233

4

Natural Sciences

3

3

95

5

Biomolecular Engineering

2

2

170

Michal Stark

×

25

Publications

1.2K

Citations

18

H-Index

YearCitations

Arabinogalactan−Folic Acid−Drug Conjugate for Targeted Delivery and Target-Activated Release of Anticancer Drugs to Folate Receptor-Overexpressing Cells

Roy I. Pinhassi, Yehuda G. Assaraf, Shimon Farber,

Biomacromolecules

2009

136

Chemotherapeutic Drug-Induced ABCG2 Promoter Demethylation as a Novel Mechanism of Acquired Multidrug Resistance

Eran Bram, Michal Stark, Shachar Raz,

Neoplasia

2009

116

Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity

Benny Zhitomirsky, Anna Yunaev, Roman Kreiserman,

Cell Death and Disease

2018

107

Imidazoacridinone-dependent lysosomal photodestruction: a pharmacological Trojan horse approach to eradicate multidrug-resistant cancers

Yamit Adar, Michal Stark, Eran Bram,

Cell Death and Disease

2012

98

Aberrant splicing of folylpolyglutamate synthetase as a novel mechanism of antifolate resistance in leukemia

Michal Stark, Chen Wichman, Irit Avivi,

Blood

2009

88

Loss of Multidrug Resistance Protein 1 Expression and Folate Efflux Activity Results in a Highly Concentrative Folate Transport in Human Leukemia Cells

Yehuda G. Assaraf, Lilah Rothem, Jan Hendrik Hooijberg,

Journal of Biological Chemistry

2003

77

Severe hypoxia induces complete antifolate resistance in carcinoma cells due to cell cycle arrest

Shachar Raz, Daoud Sheban, Nitzan Gonen,

Cell Death and Disease

2014

63

Heterogeneous Nuclear Ribonucleoprotein H1/H2-dependent Unsplicing of Thymidine Phosphorylase Results in Anticancer Drug Resistance

Michal Stark, Eran Bram, Martin Akerman,

Journal of Biological Chemistry

2010

56

Folylpolyglutamate synthetase splicing alterations in acute lymphoblastic leukemia are provoked by methotrexate and other chemotherapeutics and mediate chemoresistance

Anna Wojtuszkiewicz, Shachar Raz, Michal Stark,

International Journal of Cancer

2015

54

The Lysosomotropic Activity of Hydrophobic Weak Base Drugs is Mediated via Their Intercalation into the Lysosomal Membrane

Michal Stark, Tomás F. D. Silva, Guy Levin,

Cells

2020

54

Page 1